Related Experiment Videos
Primary effusion lymphoma (PEL) revisited: a hematologist's perspective
1Providence VA Medical Center, Providence, RI 02908, USA.
Clinical Advances in Hematology & Oncology : H&O
|September 16, 2005
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
An active post-marketing surveillance study to evaluate the safety and immunogenicity of Zyvac TCV in healthy participants.
Human vaccines & immunotherapeutics·2025
Safety Evaluation of the Novel Cocktail of Monoclonal Antibodies for Postexposure Prophylaxis in Category III Animal Exposures.
Journal of global infectious diseases·2025
Safety assessment of the world's first novel cocktail of two monoclonal antibodies in WHO category-III animal-bite patients.
Journal of family medicine and primary care·2024
Artificial intelligence in prostate cancer diagnosis and management: state-of-the-art approaches and emerging innovations.
Clinical advances in hematology & oncology : H&O·2026
Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.
Clinical advances in hematology & oncology : H&O·2026
Molecular residual disease (MRD) testing: advancing clinical decision-making in breast cancer.
Clinical advances in hematology & oncology : H&O·2026
Lamotrigine and other therapy-associated HLH syndromes: a review.
Expert review of clinical immunology·2026
BRAFV600E-Mutant Non-Langerhans Cell Histiocytosis Clonally Related to Remitted Acute Myeloid Leukemia.
Journal of cutaneous pathology·2026